Ennature Bio Pha

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE2WCT01016
  • NSEID: ENNATURE
  • BSEID: 545012
INR
168.10
-11.25 (-6.27%)
BSENSE

Nov 20

BSE+NSE Vol: 8006

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Sep'26
Jun'26
Sep'25
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is -13.20% vs 66.96% in Jun 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is 4.94% vs 464.06% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 3.61% vs 65.23% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is -25.00% vs -98.94% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Ennature Bio Pha With
Markets Mojo
Figures in Cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
78.46
32.73
45.73
139.72%
Other Operating Income
0.00
0.00
0.00
Total Operating income
78.46
32.73
45.73
139.72%
Raw Material Cost
31.09
8.12
22.97
282.88%
Purchase of Finished goods
0.00
1.52
-1.52
-100.00%
(Increase) / Decrease In Stocks
13.77
9.29
4.48
48.22%
Employee Cost
7.46
1.50
5.96
397.33%
Power Cost
4.53
0.00
4.53
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
11.26
2.55
8.71
341.57%
Total Expenditure (Excl Depreciation)
68.12
22.98
45.14
196.43%
Operating Profit (PBDIT) excl Other Income
10.34
9.75
0.59
6.05%
Other Income
0.00
0.93
-0.93
-100.00%
Operating Profit (PBDIT)
10.34
10.68
-0.34
-3.18%
Interest
0.03
1.32
-1.29
-97.73%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
10.31
9.36
0.95
10.15%
Depreciation
3.70
0.57
3.13
549.12%
Profit Before Tax
6.61
8.79
-2.18
-24.80%
Tax
1.72
2.21
-0.49
-22.17%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
4.89
6.58
-1.69
-25.68%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
4.89
6.58
-1.69
-25.68%
Equity Capital
11.17
11.96
-0.79
-6.61%
Face Value
5.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
2.19
5.50
-3.31
-60.18%
Diluted Earnings per share
2.19
5.50
-3.31
-60.18%
Operating Profit Margin (Excl OI)
13.18%
29.79%
0.00
-16.61%
Gross Profit Margin
13.14%
28.60%
0.00
-15.46%
PAT Margin
6.23%
20.10%
0.00
-13.87%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 78.46 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -13.20% vs 66.96% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 44.92%

Quarterly - Standalone Net Profit
Standalone Net Profit 4.89 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 4.94% vs 464.06% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 482.03%

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.34 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 3.61% vs 65.23% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 71.19%

Quarterly - Interest
Interest 0.03 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -25.00% vs -98.94% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -99.21%

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.18%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025